title: Veto on vedolizumab (MLN0002) for Crohn's disease.
authors.affiliation: Department of Medicine, Division of Gastroenterology and Hepatology, Charité Medical Center, Virchow Hospital, Medical School of the Humboldt, University of Berlin, Berlin, Germany.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Baumgart